Skip to content
The Nexus
DossierENTITY

global drugmakers

Coverage of global drugmakers in the Nexus archive.

Earliest in view: Jun 11 · 23:04 UTCMost recent: Jun 11 · 23:04 UTC
Co-mentioned in this coverage
Chinaplace1Hainanplace1CAR-T cancer immunotherapytopic1Bloombergorganization1Beijingplace1Chinese biopharma companiesorganization1
Recent coverage
  • HEALTHJun 11 · 23:04 UTCSEMAFOR
    Medical tourism boom in China

    China is becoming a hub for medical tourism, offering procedures like CAR-T cancer immunotherapy at significantly lower costs than in the US. The country has established a special medical tourism zone in Hainan and relaxed visa rules to attract international patients. Licensing deals between Chinese biopharma companies and global drugmakers reached $137 billion last year, driven by cost advantages in drug development.